Author

Angela Gambioli

Institution: Menarini Group (Italy)

Observed institutions: Menarini Group (Italy), University of Milano-Bicocca

ORCID: 0000-0003-2636-0189

Observed ORCID: 0000-0003-2636-0189

OpenAlex ID: A5087164726

Effect of laparoscopic sleeve gastrectomy vs laparoscopic sleeve + Rossetti fundoplication on weight loss and de novo GERD in patients affected by morbid obesity: a randomized clinical study

2022 · Stefano Olmi, Giovanni Cesana, et al. · Obesity Surgery · 32

Correction to: Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Sleeve + Rossetti Fundoplication on Weight Loss and De Novo GERD in Patients Affected by Morbid Obesity: a Randomized Clinical Study

2022 · Stefano Olmi, Giovanni Cesana, et al. · Obesity Surgery · 3

Abstract P2-08-20: ELCIN: Elacestrant in women and men with CDK4/6 inhibitor (CDK4/6i)-naïve estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer (mBC): An open-label multicenter phase 2 study

2025 · Virginia Kaklamani, Giorgi Dzagnidze, et al. · Clinical Cancer Research

ELCIN: Elacestrant in women and men with CDK4/6 inhibitor (CDK4/6i)-naïve estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer (mBC)—An open-label multicenter phase 2 study.

2025 · Virginia G. Kaklamani, Giorgi Dzagnidze, et al. · Journal of Clinical Oncology

Abstract CT236: ELCIN: Elacestrant (Ela) in women and men with CDK4/6 inhibitor (CDK4/6i)- naive estrogen receptor- positive (ER+), HER2-negative (HER2-) metastatic breast cancer (mBC): An open-label multicenter phase 2 study

2025 · Virginia Kaklamani, Giorgi Dzagnidze, et al. · Cancer Research

Works count: 5

Citation count: 35

H-index: 2

I10-index: 1